Introduction and Chemical Classification Orphenadrine is a pharmaceutical agent classified primarily as an anticholinergic drug, specifically a tertiary amine derivative. Chemically, it is closely related to diphenhydramine and structurally similar to other ethanolamine antihistamines, though its clinical application is centered on its muscle relaxant and antiparkinsonian effects rather than its antihistaminic properties, which are secondary. […]
Introduction and Definition of Parkinsonism Parkinsonism is defined broadly within the field of neurology and psychopathology as a specific clinical syndrome characterized by a constellation of motor symptoms that closely resemble those observed in idiopathic Parkinson’s Disease (PD). Crucially, Parkinsonism is not synonymous with PD; rather, it is the overarching descriptive term for any disorder […]
Introduction and Definition Progressive Supranuclear Palsy, often abbreviated as PSP, is a complex and debilitating neurodegenerative disorder belonging to the group of conditions known as atypical parkinsonism. It is fundamentally characterized by the progressive deterioration of specific neural pathways, leading prominently to severe oculomotor palsy, particularly affecting the vertical plane, and profound postural instability. Unlike […]
Introduction and Definition of Paralysis Agitans The term Paralysis Agitans stands as a critical historical marker within the field of neurology, serving as the archaic designation for what is now universally known as Parkinson’s Disease (PD). This nomenclature, literally translating to “shaking paralysis,” was formally introduced by the English physician Dr. James Parkinson in his […]